All blueprints

Quality agreements.

Turn written responsibilities into routed work, evidence and accountable decisions.

Illustration of a seal beside an open evidence folio containing SOP, training and execution records.
A pharmaceutical quality agreement responsibility matrix across sponsor, CDMO and contract laboratory

Executable quality-agreement matrix

Scroll to explore the full-size diagram.

How to read this diagram

Written responsibilities resolve against the product, service, site and actual event—with evidence and timing attached.

Applicability
Product, market, site, method and subcontractor determine which duty applies.
Authority
Performing work and owning the final decision remain distinct responsibilities.
Evidence
Deliverable, source, deadline and escalation are part of every obligation.
Gap
Uncovered subcontracted work is blocked rather than hidden in a signed PDF.

Figure 1. Quality agreement QA-018 v06 for Product A in the US and EU assigns each activity to the sponsor, CDMO and contract laboratory with its evidence and clock. A live gap shows that subcontract laboratory CL-09 is not covered, so method AM-081 work is blocked until the amendment takes effect.

Summary

The problem
Responsibilities agreed with a CDMO, laboratory or supplier sit in a signed PDF, and teams interpret them from memory while notification and investigation clocks run.
Seal’s approach
Each responsibility becomes a structured obligation resolved against the products, batches, samples, changes and events it governs, with its performer, approver, evidence and clock.
What changes
The live case shows which party must act and by when, revisions assign open work to old or new terms, and periodic review compares the agreement with actual practice.
Where to start
One outsourced batch followed end to end through every agreed clock and handoff. Book a demo.

1A quality agreement governs the work after signature.

A quality agreement sets the operating boundary between the parties: who performs, reviews, approves, notifies, investigates, supplies records, releases, retains, audits and escalates each regulated activity. Its value lies in how the work runs after signature, which a signed PDF in a contract repository cannot show.

Seal turns those responsibilities into obligations connected to actual products, sites, batches, samples, changes, deviations and decisions, so both parties can show that the agreed operating model is the one in use.

FDA’s quality agreements guidance for contract drug manufacturing is the primary US reference for defining and documenting each party’s manufacturing activities while preserving each party’s CGMP responsibilities. The owner’s quality unit remains responsible for approving or rejecting product made under contract.¹

2Structure responsibilities instead of burying them in prose.

Scope starts with the legal entities, sites, quality units, authorised contacts, products, markets, subcontractors and effective dates. Each regulated service (manufacturing, testing, release, storage, transport or complaint handling, for example) can be included independently. Commercial terms stay outside the quality workflow unless they create a regulated obligation.

Each activity then names the accountable party, performer, reviewer, approver, parties to notify, evidence provider, timing, governing procedure and escalation. The controlled narrative is generated from those obligations, so overlaps and unassigned activities are visible before approval. Applicability rules show which obligation governs each batch or sample when one relationship covers several products, methods and sites. A corporate template can supply defaults without treating an aseptic CDMO, a microbiology laboratory and a warehouse as if they needed the same controls.

2.1Why teams choose Seal for quality agreements

A contract repository stores the signed PDF, and the teams on both sides interpret it from memory while notification and investigation clocks run. Seal resolves each obligation against the batches, samples, changes and events it governs, so the agreement routes work and shows whether each promised control happened on time, with the right evidence and the accountable party. When the agreement is revised, open work is assigned to the old or new terms explicitly, rather than left to whoever remembers the change.

Table 1. Where an operational quality agreement differs from a stored one.
Agreement stored as a documentSeal
ResponsibilitiesClauses in prose, interpreted when neededStructured obligations by activity, party and product
During an eventSomeone searches the PDF while the clock runsThe live case shows the applicable obligation and its clock
RevisionsA new signed versionObligation-level differences with open work assigned to old or new terms
Periodic reviewA reread of the documentWritten responsibilities compared with actual practice

3Keep procedures, records and data exchange explicit.

The agreement identifies whose procedure governs, how differences are reconciled, who authors and approves each record, which system is authoritative, and how certified copies, retention and inspection support work. System access does not transfer accountability: each party keeps the signatures and decisions assigned to it.

Contract laboratory / one order across two trust boundaries
The client sees a coherent service state. Internal work retains its richer GMP evidence, and per-client Systems keep each client’s records apart.
SO-NOVA-01804
08:14
09:02
11:40
15:22
D+3
Client portal
Request
7 tests / 5d
Received
temp query
In testing
4 / 7
Action
OOS ack
Delivered
CoA v01
CLIENT SYSTEM BOUNDARY
Accession
conditional
Aliquot
ready
HPLC assay
complete
OOS notice
client ack
QA / CoA
released
Lab operation
Accession
method · sample · analyst
instrument · source data
conditional
Aliquot
method · sample · analyst
instrument · source data
ready
HPLC assay
method · sample · analyst
instrument · source data
complete
OOS notice
method · sample · analyst
instrument · source data
client ack
QA / CoA
method · sample · analyst
instrument · source data
released
Reconcile
Promise
5 business days
Actual
3d 04h · OOS clock met
Invoice basis
7 tests · 1 client retest
Figure 2. Client, contract site, source records, shared decisions and release evidence remain separated by responsibility but connected by one operating timeline

Data exchange has content and timing requirements. Batch records, raw data, audit trails, certificates, stability data and investigations can each have a required format, completeness, transfer method and deadline. Receipt and acceptance are separate states, and missing metadata or an unreadable native file remains an open obligation.

4Make notifications and investigations follow the agreed rules.

A change to a process, material, method, specification, equipment, site or subcontractor can require pre-approval, prior notification, prompt notification or periodic reporting. Seal resolves the applicable obligation, required information, recipients, due clock and implementation conditions.

For deviations and OOS results, the agreement sets notification thresholds and timelines, containment, who leads the investigation, data access, retest authorisation, product impact, CAPA and report approval. Complaints, recalls and safety signals resolve to named parties and clocks in the same way. The live case shows what the agreement requires for this product and service, and each event keeps the obligation version in effect when it occurred, even if the agreement is later revised.

5Separate manufacture, certification and release.

Manufacturing review, testing, deviation closure, CoA issue, disposition recommendation, certification by a qualified or authorised person, sponsor release and shipment authorisation can belong to different parties.² Each decision keeps its prerequisite evidence, authority, signature, conditions and handoff. Hosting the system does not let one party approve a step assigned to another.

6Oversee subcontractors, audits and performance against the promised controls.

Approved subcontractors keep their service, site, qualification, sponsor consent, agreement, oversight and audit rights. Delegation by one party does not remove the original party’s responsibility, and a subcontractor change identifies the products, methods, records and commitments it affects.³

Audit scope, observations, responses and CAPA connect to the services and obligations assessed. Repeated findings can reveal an obligation that is poorly defined, or a control that is not working across several products. Performance measures, such as notification timeliness, on-time records, investigation cycle time and data completeness, use defined denominators and stay linked to actual cases. A poor score opens the evidence rather than ending the conversation.

7Revise, review and terminate with the operations in view.

A proposed revision shows obligation-level differences and the affected products, records, systems, procedures, training, contacts and open events. Both parties review and approve the same change. Open batches, samples, investigations and changes are explicitly assigned to the old or new terms; signature alone does not make an agreement operational.

Periodic review compares the written responsibilities with actual practice: deviations, changes, release performance, data exchange, audits and open commitments. Differences become actions, agreement changes, training, system changes or service restrictions. At termination, final batches, retained samples, stability, complaints, records and regulatory commitments receive an explicit disposition. Ending the commercial service does not close the quality obligations that survive it.

Each organisation can keep its own QMS, LIMS, MES, DMS and identity system. Seal supports controlled exchange, client-specific visibility, verified copies, source links and decision handoffs. Where both parties use Seal, tenant and permission boundaries keep them separate while shared records expose only the agreed evidence and actions.

8Prove one outsourced batch end to end.

Start with one sponsor product and follow it through material sourcing, contract manufacture, external testing, a deviation, a change notification, record transfer, CoA, sponsor disposition, shipment and periodic review.

Include the difficult cases: a late notification, missing raw-data metadata, a disputed investigation conclusion, retest authorisation, a subcontracted assay and an agreement revision. The first release should route the batch through every agreed clock and handoff, surface any uncovered subcontractor before work begins and leave no decision dependent on remembering who is responsible.

References

  1. 121 CFR 211.22, Responsibilities of quality control unit: a quality control unit must have the responsibility and authority to approve or reject components, in-process materials, packaging, labelling and drug products, and to review production records. eCFR
  2. 2EudraLex Volume 4, Annex 16, Certification by a Qualified Person and Batch Release (2015), sections 1 (the process of certification) and 3 (handling of unexpected deviations). European Commission
  3. 3EudraLex Volume 4, Part I, Chapter 7, Outsourced Activities (2013). European Commission

AOperating model

Included in this blueprint

  • Structured responsibility matrix
  • Product and service applicability
  • Change notification control
  • Record exchange completeness
  • Living agreement review

Connected across Seal

BCapabilities

Table B.1. What the Pharmaceutical Quality Agreements and External Partner Governance blueprint covers. Linked capabilities are blueprints of their own.
CapabilityWhat it covers
Structured responsibility matrixAccountable, performing, reviewing, approving, consulted, notified, evidence-owning, timing and escalation duties become governed obligations.
Product and service applicabilityProducts, sites, methods, markets, services, lifecycle stages and subcontractors resolve the correct obligations for actual work.
Change notification controlTriggers, required content, recipients, deadlines, questions, assessments, approvals, implementation conditions and acknowledgements remain enforceable.
Shared event governanceDeviation, OOS, complaint, recall, CAPA and audit cases use agreed thresholds, decision rights, evidence access, clocks and approvals.
Record exchange completenessRequired records, native data, metadata, format, source, timing, transfer, receipt, review, exceptions and acceptance remain visible.
Delegated release decisionsManufacturing review, certification, testing, CoA, sponsor disposition, market release and shipment authority retain separate prerequisites and signatures.
Relationship performanceTimeliness, right-first-time, events, investigation quality, data completeness, release, complaints, audits and CAPA use linked evidence and denominators.
Living agreement reviewWritten obligations reconcile with actual practice, current contacts, subcontractors, systems, performance, events, regulations and surviving duties.

CConnected records

Entity hierarchy
What it records
Kind
Quality Relationship
Parties, legal entities, sites, services, products, markets, contacts and effective scope.
entity
Sponsor–CDMO Relationship
Product and site scope, manufacturing and testing services, contacts, systems and oversight pattern.
template
Northstar / Houston CDMO
Commercial sterile-product relationship covering manufacture, QC, release support and stability.
record
Quality Obligation
Activity, accountable party, performer, reviewer, approver, timing, evidence and escalation.
entity
Significant Change Notification
Change classes, notice timing, information, sponsor assessment, approval and implementation conditions.
template
OBL-4.7 / Prior Approval
Sponsor approval required before implementing critical material or process changes.
record
Quality Agreement
Governed obligation set, applicability, narrative, signatures, versions and effective transition.
entity
Commercial Drug Quality Agreement
Responsibilities for materials, manufacture, testing, change, events, release, records, audits and review.
template
QAG-TX10 v06
Effective agreement governing TX-10 manufacture and testing at Houston.
record
Outsourced Service
Manufacturing, testing, packaging, storage, distribution, safety or other regulated activity.
entity
Quality Notification
Trigger, obligation, content, recipient, due time, delivery, questions, acceptance and closure.
entity
Cross-Party Deviation Notice
Threshold, immediate content, recipient, clock, updates, investigation report and acknowledgement.
template
QN-2026-0229
Late notification of a fill-line intervention deviation for batch TX10-026.
record
Record Exchange
Required records, source, format, metadata, timing, delivery, receipt, completeness and acceptance.
entity
Batch Release Record Exchange
Required document and data manifest, source metadata, delivery clock, completeness checks, questions and acceptance.
template
XFER-TX10-026
Release package with one missing environmental-monitoring attachment held open to the accountable party.
record
Shared Quality Event
Deviation, OOS, change, complaint, recall, audit, CAPA or other cross-party case and rights.
entity
Delegated Decision
Review, approval, certification, disposition, release, implementation or closure by assigned authority.
entity
Relationship Performance
Governed metrics, populations, targets, cases, trends, review, escalation and actions.
entity
Agreement Review
Scope, obligations, practice, performance, issues, regulatory change, gaps, actions and approval.
entity
Figure C.1. Record types, templates and the relationships between them in this blueprint.

DQuestions and answers

What is pharmaceutical quality agreement software?

It turns cross-company GMP responsibilities into governed obligations connected to real products, services, records, changes, events, decisions, performance and periodic review.

How is this different from contract management?

Contract tools manage legal and commercial documents. Seal manages operational quality responsibilities, applicability, notification clocks, evidence, decision rights, regulated records and proof of performance.

Can Seal create a responsibility matrix?

Yes. Each activity can identify accountable, performing, reviewing, approving, consulted, notified, evidence-owning, timing, procedure and escalation responsibilities by product and service.

Can different products use different obligations?

Yes. Product, site, market, method, service, lifecycle stage and effective dates resolve which agreement clauses and responsibilities apply to each actual batch, sample or event.

How are changes notified between parties?

Change classes trigger the correct obligation, content, recipient, due clock, questions, impact assessment, pre-approval or acknowledgement, implementation conditions and final effective state.

How are OOS investigations handled?

The agreement defines notification, investigation lead, raw-data access, hypothesis and retest authorisation, review rights, product impact, report approval, CAPA and closure for the applicable service.

Can Seal support separate sponsor and CDMO systems?

Yes. Source systems can remain authoritative while Seal controls obligations, exchange packages, verified copies, acknowledgements, shared actions, decision handoffs and client-specific visibility.

How are subcontractors managed?

Subcontractor service, site, qualification, consent, agreement, information flow, oversight, audits, changes, records and termination remain connected through the delegation chain.

Can quality agreements govern batch release?

Yes. Manufacturing review, testing, certification, CoA, sponsor disposition, market release and shipment authorisation can each retain assigned authority and prerequisites.

How are agreement revisions implemented?

Obligation-level differences identify products, services, systems, procedures, training, contacts, open work, and transition tasks. Both parties approve before effective use.

What belongs in periodic review?

Scope, contacts, licences, subcontractors, obligations, actual practice, notifications, events, release, data exchange, audits, CAPA, complaints, recalls, metrics, regulations and open commitments.

What should the first implementation prove?

Trace one outsourced batch through manufacture, external testing, deviation, change notification, record exchange, delegated release, shipment, complaint, performance review and agreement revision.

See your process in Seal.

Bring a procedure or a recurring problem. See how your team can use Neil to build the workflow, investigate the results and improve the next version.

Book a demo